Drawing for VELLAFILM

USPTO serial 98524059

VELLAFILM

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
REINHART, MEGHAN M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with VELLAFILM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Molly B. Markley

Molly B. Markley Young, Basile, Hanlon & MacFarlane P.C.3001 West Big Beaver RoadSuite 624Troy, MI 48084

Goods and services

ClassDescriptionStatusFirst use
005Medical, veterinary and surgical dressings; medical, surgical and veterinary topical anti-septic and anti-bacterial preparations for wound care; medical, surgical and veterinary anti-septic dressings for wound care; medical, surgical and veterinary anti-bacterial dressings for wound care; silicone films sold as an integral part of film dressings for dressing wounds; wound dressings for medical, veterinary, and surgical purposes; dressing materials for wounds namely, medical adhesive tape, gauze, bandages, wadding for medical purposes, and alginates for medical purposes; dressings for wounds for medical, veterinary, and surgical purposes; materials for medical use in covering wounds, namely, medical adhesive tape, gauze, bandages, wadding for medical purposes, and alginates for medical purpose; self-adherent wound dressings for medical, veterinary, and surgical purposes; absorbent wound dressings for medical, veterinary, and surgical purposes; super-absorbent wound dressings for medical, veterinary, and surgical purposes; medical, veterinary, and surgical dressings incorporating super-absorbent materials; dressings for medical, veterinary, and surgical purposes for the management of exudate from wounds; dressings for medical, veterinary, and surgical purposes shaped to fit the contours of the body; bandages for dressings; antiseptic dressings for medical, veterinary, and surgical purposes; antibacterial dressings for medical, veterinary, and surgical purposes; dressings containing pharmaceutical preparations for medical, veterinary, and surgical purposes; dressings containing antiseptic preparations for medical, veterinary, and surgical purposes; dressings containing antibacterial preparations for medical, veterinary, and surgical purposes; materials for dressings namely, medical adhesive tape, gauze, bandages, wadding for medical purposes, and alginates for medical purposes; materials for medical use in packing wounds, namely, adhesive tape, gauze, bandages, wadding, and alginates; dressing retention materials in the nature of adhesive silicone medical tape, adhesive medical tape, dressing ribbon being wound dressings, and bandages for dressings; materials that adhere to the skin for the location of dressings, namely, adhesive medical tape, medical adhesive tape, dressing ribbon being wound dressings, and adhesive bandages; adhesive materials for the location of dressings, namely, adhesive silicone medical tape, medical adhesive tape, dressing ribbon being wound dressings, and adhesive bandages; self-adhesive sterile tape for wound dressing for medical, veterinary, and surgical purposes; articles and adhesives for use in securing bandages, namely adhesive silicone tape for medical purposes, and medical adhesive tape; sterilising preparations; antiseptics; solvents for removing adhesive plasters and dressings; medicated tissues impregnated with pharmaceutical lotion for skin conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 27, 2026EX2GSOU EXTENSION 2 GRANTED—
Oct 27, 2026EXT2SOU EXTENSION 2 FILED—
Oct 27, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 24, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 23, 2026EX1GSOU EXTENSION 1 GRANTED—
Feb 23, 2026EXT1SOU EXTENSION 1 FILED—
Feb 23, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 28, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 29, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jul 29, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 29, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 29, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 24, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 24, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 28, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 20, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 25, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2024DOCKASSIGNED TO EXAMINER—
Apr 29, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance